Faculty profile
Amritanshu Pandey
Back to facultyResearch
Research areas are derived from OpenAlex topics of their publications.
54 publications.
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
Azizi M, Brown JM, Dwyer JP, Flack JM, Jones ESW, Kurlyandskaya R, Li H, Birve F, Lihn AS, Perl S
Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies A Phase 3 Randomized Clinical Trial
Catapano AL, Mikhailova E, Navar AM, Banka P, Corral P, Saxena M, Steg PG, Verma S, Kordahi AY, Mendizabal G
Clinical Care for Patients With Elevated Lipoprotein(a) Level in Canada: A Practical Framework for Screening, Risk Assessment, and Management
Thanassoulis G, Anand S, Arsenault BJ, Bainey KR, Bell AD, Brunham LR, Iatan I, Koschinsky ML, Leiter LA, Mehta SR
Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study
Navar AM, Bai L, Højen JF, Ivanes F, Kristensen SL, Lam CSP, Landmesser U, Lee K, Liuzzo G, Maia LN
Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial
Rivard L, Khairy P, Talajic M, Tardif J-C, Healey JS, Black SE, Andrade JG, Field TS, Nault I, Bherer L
Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial
Rivard L, Khairy P, Talajic M, Tardif J-C, Healey JS, Black SE, Andrade JG, Field TS, Nault I, Bherer L
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Kosiborod MN, Windsor SL, Vardeny O, Berger JS, Reynolds HR, Boumakis S, Althouse AD, Solomon SD, Bhatt AS, Peikert A
Self-Administered Etripamil Nasal Spray Relieved Symptoms, Decreased Heart Rate, and Reduced Medical Interventions During Atrioventricular Nodal–Dependent Paroxysmal Supraventricular Tachycardia
Stambler BS, Coutu B, Ip JE, Mondésert B, Pandey AS, Sager PT, Wight D, Plat F, Shardonofsky S, Bharucha DB
VAPING CESSATION INTERVENTIONS: A SYSTEMATIC REVIEW AND META ANALYSIS
Heshmati J, Pandey A, Benjamen J, Furqan M, Salman M, Visintini S, Mullen K, Guyatt G, Pipe A, Mir H
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Stambler BS, Camm AJ, Alings M, Dorian P, Heidbuchel H, Houtgraaf J, Kowey PR, Merino JL, Mondésert B, Piccini JP
Frequent collaborators
20Shamir Mehta
Medicine
10 shared papers, latest 2026
Koon Teo
Medicine
7 shared papers, latest 2010
Gilmar Reis
Health Research Methods, Evidence, and Impact
6 shared papers, latest 2019
Jeff Healey
Medicine
5 shared papers, latest 2026
Akbar Panju
Medicine
2 shared papers, latest 2006
Dominic Raco
Medicine
2 shared papers, latest 2006
Researchers with similar interests
Jorge Wong
Medicine
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments
William McIntyre
Medicine
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments
Jeff Healey
Medicine
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments
Guy Amit
Medicine
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments
Rupinder Sahsi
Family Medicine
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments
Syamkumar M. Divakara Menon
Medicine
Atrial Fibrillation Management and Outcomes, Cardiac Arrhythmias and Treatments
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.